BRIEF published on 11/12/2024 at 09:56, 1 year ago KSB Maintains Growth Trajectory in 2024 Order Intake Sales Revenue EBIT Increase KSB Growth SupremeServ Segment
PRESS RELEASE published on 11/12/2024 at 09:51, 1 year ago KSB continues on its growth path KSB SE & Co. KGaA reports growth in order intake, sales revenue, and EBIT for the first nine months of 2024. Strong performance by the KSB SupremeServ Segment drives development EBIT Order Intake Sales Revenue Growth KSB
BRIEF published on 07/31/2024 at 09:11, 1 year 4 months ago KSB Achieves Solid Growth in First Half of 2024 Despite Economic Challenges Order Intake Sales Revenue Financial Growth KSB SupremeServ Earnings (EBIT)
PRESS RELEASE published on 07/31/2024 at 09:06, 1 year 4 months ago KSB achieves solid growth in the first half of 2024 – undeterred by the economic headwind KSB reports solid growth in H1 2024, with increased order intake, sales revenue, and EBIT; SupremeServ Segment excels. Annual forecast confirmed EBIT Order Intake KSB Solid Growth H1 2024
BRIEF published on 05/08/2024 at 17:00, 1 year 6 months ago KSB SE & Co. KGaA Announces Record Results and Strategic Plans at Annual General Meeting Dividend Increase KSB SE & Co. KGaA Financial Results 2023 2024 Financial Outlook Investment Plans
PRESS RELEASE published on 05/08/2024 at 16:55, 1 year 6 months ago Record Figures at KSB’s Annual General Meeting KSB SE & Co. KGaA achieved record figures at its Annual General Meeting, with significant increases in order intake, sales revenue, and earnings. The company announced a dividend of €26.00 per ordinary share Annual General Meeting Financial Performance Dividend KSB SE & Co. KGaA Record Figures
BRIEF published on 04/25/2024 at 09:14, 1 year 7 months ago KSB Continues Positive Growth in Q1 2024 Despite Global Economic Challenges KSB Financial Growth Quarterly Performance 2024 Pump And Valve Manufacturing Global Economic Impact Corporate Earnings Report
PRESS RELEASE published on 04/25/2024 at 09:09, 1 year 7 months ago KSB continues the positive trend of the previous year in the first quarter of 2024 KSB SE & Co. KGaA continues positive trend with strong order intake, sales revenue, and earnings growth in the first quarter of 2024 Order Intake Sales Revenue KSB SE & Co. KGaA Earnings Growth Positive Trend
BRIEF published on 03/26/2024 at 10:15, 1 year 8 months ago KSB Ends 2023 with Unprecedented Financial Success Financial Performance Dividend Proposal Record Revenue Annual Report 2023 KSB
PRESS RELEASE published on 03/26/2024 at 10:10, 1 year 8 months ago KSB closes the 2023 financial year with record performance KSB closed the 2023 financial year with record performance, achieving high order intake, sales revenue, and earnings, along with an increased EBIT margin. The dividend proposal is €26.00 per ordinary share Financial Year EBIT Margin Dividend Proposal KSB Record Performance
Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 17 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
